Frontiers | Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers
PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer - ScienceDirect
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer | PNAS
Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells | Scientific Reports
Predictive Markers for the Efficacy of Anti–PD-1/PD-L1 Antibodies in Lung Cancer - ScienceDirect
The diverse functions of the PD1 inhibitory pathway | Nature Reviews Immunology
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity | Nature
Anti-PDL-1 Antibody Treatment Reduces Expression of the Exhaustion Marker PD -1 in T Cells | Biocompare Antibody Review
Effect of blocking PD-1 and PD-L1 on immune checkpoint and Treg-related... | Download Scientific Diagram
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text
Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy - ScienceDirect
PD-L1 expression on nonclassical monocytes reveals their origin and immunoregulatory function | Science Immunology
PD-1 is imprinted on cytomegalovirus-specific CD4+ T cells and attenuates Th1 cytokine production whilst maintaining cytotoxicity | PLOS Pathogens
Frontiers | PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
PD-1-high TILs: a predictive biomarker for ICB in lung cancer
Role of PD-1 during effector CD8 T cell differentiation | PNAS
Identification and Validation of a PD-L1 Binding Peptide for Determination of PDL1 Expression in Tumors | Scientific Reports
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors | Molecular Cancer | Full Text
Raji-hPD-1 cells | ADCC targets | InvivoGen
IVD Antibody Development Services for PD-L1 Marker - Creative Biolabs
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
High IL-8 correlates with reduced response to PD-1/PD-L1 checkpoint blockade
Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses | Science
